re: good volume Best of all Pharmaxis is targetting large, underserved markets ($15 Billion worth) when you tally Asthma, Chronic Bronchitis, Cystic Fibrosis, Rheumatoid Arthritis & Mulitple Schelorosis treatments.
No need to ramp this one....just need a little patience
As always DYOR.
re: good volume Best of all Pharmaxis is targetting large,...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.002(4.65%) |
Mkt cap ! $56.29M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.3¢ | 4.0¢ | $121.5K | 3.004M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 649826 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 959182 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |